Fact sheet: Variopartner SICAV MVGbMdtcF

Fund information
Fund name
Variopartner SICAV MIV Global Medtech Fund N3 USD
Fund manager company
Vontobel Asset Management S.A.
Fund type
Offshore Fund
Fund manager
  • MIV Asset Management AGsince 11/03/2008
Fund objective
This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the Sub-Fund's total assets are invested directly or indirectly in participation certificates (stocks and shares, participation certificates, etc.) from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology. Furthermore, the Sub-Fund can also hold up to one third of its total net assets in liquid assets. The liquid assets are held in CHF or other freely convertible currencies. The foreign currency risks in the Sub-Fund may be hedged. Investments in other UCITS or UCI are not permitted.
Benchmark
  • MSCI World Healthcare Equipment & Supplies
Investment style
None
Investment method
Shares
Quick stats
1 Year return
3.4%
1 Year rank in sector
4/31
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
1.21%
Fund size
£662m (£648m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
114
Top in this sector
Fund name1 Year
Pictet Health4.9%
Fidelity Gbl Health Care4.2%
BB Medtech4%
Variopartner SICAV MVGbMdtcF3.4%
Variopartner SICAV SEmMkHcare-0.5%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund-4.2%-9.6%-6.9%3.4%--
Sector0.5%-6.2%-3.4%-9.5%23.9%107.7%
Rank within sector31 / 3228 / 3222 / 324 / 31--
Quartile4th4th3rd1st
Calendar performance
 YTD - 20162015201420132012
Fund3.1%7.2%---
Sector-11.2%7.2%28.1%41%16.7%
Rank within sector3 / 3119 / 29---
Quartile1st3rd
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
-
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
-
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
-
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
-
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
-
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
-
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
-
Price movement
52 week high1514.17
52 week low1166.21
Current bid price-
Current offer price-
Current mid price1348.01
Region
1International100%
Industry sector
1Pharmaceuticals100%
Asset type
1International Equities100%
Individual holdings
1ABBOTT LABORATORIES9%
2Boston Scientific Corp ORD9%
3MEDTRONIC INC9%
4STRYKER CORP7%
5BECTON DICKINSON & CO6%
6BAXTER INTERNATIONAL INC4%
7DAVITA INC4%
8GN STORE NORD4%
9ST JUDE MEDICAL INC4%
Management
Fund manager group
Vontobel Fund Management
Fund manager company
Vontobel Asset Management S.A.
Fund type
Offshore Fund
Fund objective
This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the Sub-Fund's total assets are invested directly or indirectly in participation certificates (stocks and shares, participation certificates, etc.) from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology. Furthermore, the Sub-Fund can also hold up to one third of its total net assets in liquid assets. The liquid assets are held in CHF or other freely convertible currencies. The foreign currency risks in the Sub-Fund may be hedged. Investments in other UCITS or UCI are not permitted.
Benchmark
  • MSCI World Healthcare Equipment & Supplies
Investment style
None
Investment method
Shares
Fund manager
NameSinceBiography
MIV Asset Management AG11/03/2008
Compliance
Transparent for Austrian Tax, Transparent for Swiss Tax, Transparent for German Tax, Reporting Fund Status, UCITS V Compliant
Domicile
No data available.
Fund for sale in
Austria, Switzerland, Germany, United Kingdom, Liechtenstein, Luxembourg, Netherlands, Offshore
Variopartner SICAV MIV Global Medtech Fund I1 CHF
Initial charge5%
Annual charge0.8%
Min single investment£500,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.01%
Total expense ratio (TER)1.03%
Bid price-
Offer price-
Mid price1381.09
CurrencyCHF
Price updated07/12/2016
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeG6C9
Variopartner SICAV MIV Global Medtech Fund I2 EUR
Initial charge5%
Annual charge0.8%
Min single investment£300,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.01%
Total expense ratio (TER)1.03%
Bid price-
Offer price-
Mid price1274.23
CurrencyEUR
Price updated07/12/2016
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeMCG5
Variopartner SICAV MIV Global Medtech Fund I3 USD
Initial charge5%
Annual charge0.8%
Min single investment£500,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.01%
Total expense ratio (TER)1.02%
Bid price-
Offer price-
Mid price1371.81
CurrencyUSD
Price updated07/12/2016
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeFDWT
Variopartner SICAV MIV Global Medtech Fund N3 USD
Initial charge5%
Annual charge1%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.21%
Total expense ratio (TER)1.21%
Bid price-
Offer price-
Mid price1348.01
CurrencyUSD
Price updated07/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeFJAH
Variopartner SICAV MIV Global Medtech Fund P1 CHF
Initial charge5%
Annual charge1.4%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.61%
Total expense ratio (TER)2.34%
Bid price-
Offer price-
Mid price1309.71
CurrencyCHF
Price updated07/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeG6D0
Variopartner SICAV MIV Global Medtech Fund P2 EUR
Initial charge5%
Annual charge1.4%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.61%
Total expense ratio (TER)1.63%
Bid price-
Offer price-
Mid price1208.45
CurrencyEUR
Price updated07/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeMCG4
Variopartner SICAV MIV Global Medtech Fund P3 USD
Initial charge5%
Annual charge1.4%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.61%
Total expense ratio (TER)1.62%
Bid price-
Offer price-
Mid price1300.58
CurrencyUSD
Price updated07/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeFDKE
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.